We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Zoetis Inc (ZTS) USD0.01

Sell:$164.60 Buy:$164.72 Change: $1.32 (0.81%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$164.60
Buy:$164.72
Change: $1.32 (0.81%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$164.60
Buy:$164.72
Change: $1.32 (0.81%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

Contact details

Address:
10 Sylvan Way
PARSIPPANY
07054
United States
Telephone:
+1 (973) 8227000
Website:
https://www.zoetis.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ZTS
ISIN:
US98978V1035
Market cap:
$75.35 billion
Shares in issue:
451.17 million
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Kristin Peck
    Chief Executive Officer, Director
  • Wetteny Joseph
    Chief Financial Officer, Executive Vice President
  • Jared Shriver
    President, U.S. Operations
  • Roxanne Lagano
    Executive Vice President, Chief Human Resource Officer, Global Operations, Interim General Counsel, Corporate Secretary
  • Keith Sarbaugh
    Executive Vice President, Chief Digital and Technology Officer
  • Nicholas Ashton
    Executive Vice President, President - Global Manufacturing and Supply
  • Jeannette Astorga
    Executive Vice President - Corporate Affairs, Communications, Chief Sustainability Officer
  • Jamie Brannan
    Executive Vice President, Chief Commercial Officer
  • Rimma Driscoll
    Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
  • Robert Polzer
    Executive Vice President, President - Research and Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.